Minimal residual disease monitoring via AML1-ETO breakpoint tracing in childhood acute myeloid leukemia

Relapse of childhood AML1-ETO (AE) acute myeloid leukemia is the most common cause of treatment failure. Optimized minimal residual disease monitoring methods is required to prevent relapse. In this study, we used next-generation sequencing to identify the breakpoints in the fusion gene and the DNA-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Transl Oncol
Autors principals: Chen, Xiaoyan, Zong, Suyu, Yi, Meihui, Liu, Chao, Wang, Bingrui, Duan, Yongjuan, Cheng, Xuelian, Ruan, Min, Zhang, Li, Zou, Yao, Chen, Yumei, Yang, Wenyu, Guo, Ye, Chen, Xiaojuan, Hu, Tianyuan, Cheng, Tao, Zhu, Xiaofan, Zhang, Yingchi
Format: Artigo
Idioma:Inglês
Publicat: Neoplasia Press 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8138770/
https://ncbi.nlm.nih.gov/pubmed/34000643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2021.101119
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars